Home - Products - Others - Other Targets - 3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one

3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one

CAS No. 1220891-22-4

3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one( —— )

Catalog No. M30857 CAS No. 1220891-22-4

3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 495 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one
  • Note
    Research use only, not for human use.
  • Brief Description
    3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one is a natural product for research related to life sciences.
  • Description
    3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1220891-22-4
  • Formula Weight
    178.2
  • Molecular Formula
    C10H10O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Interiorin

    Interiorin can be isolated from Kadsura heteroclita and has moderate anti-HIV activity with an EC50 value of 1.6 lg/mL.

  • 2-(5,7-dichloro-1H-i...

    2-(5,7-dichloro-1H-indol-3-yl)ethan-1-amine is a chemical compound.

  • C004019

    C004019 is a small molecule PROTAC capable of targeting tau for selective protein degradation from the cell, while recruiting tau and E3 ligase (Vhl) for selective enhancement of tau ubiquitination and proteollyzation. C004019 is a candidate for AD and related tau protein diseases.